| Original language | English |
|---|---|
| Pages (from-to) | 1191-1199 |
| Number of pages | 9 |
| Journal | Pharmacoepidemiology and Drug Safety |
| Volume | 27 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - Nov 2018 |
Keywords
- chronic obstructive pulmonary disease
- eosinophils
- exacerbations
- inhaled corticosteroids
- pharmacoepidemiology
- OBSTRUCTIVE PULMONARY-DISEASE
- PRACTICE RESEARCH DATALINK
- CLINICAL-PRACTICE
- COMORBIDITIES
- COUNT
- PREVENTION
- PNEUMONIA
- STABILITY
- BIOMARKER
- MARKERS
Cite this
}
Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality. / Oshagbemi, Olorunfemi A.; Franssen, Frits M. E.; Braeken, Dionne C. W.; Henskens, Yvonne; Wouters, Emiel F. M.; Maitland-van der Zee, Anke-Hilse; Burden, Andrea M.; de Vries, Frank.
In: Pharmacoepidemiology and Drug Safety, Vol. 27, No. 11, 11.2018, p. 1191-1199.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
AU - Oshagbemi, Olorunfemi A.
AU - Franssen, Frits M. E.
AU - Braeken, Dionne C. W.
AU - Henskens, Yvonne
AU - Wouters, Emiel F. M.
AU - Maitland-van der Zee, Anke-Hilse
AU - Burden, Andrea M.
AU - de Vries, Frank
PY - 2018/11
Y1 - 2018/11
KW - chronic obstructive pulmonary disease
KW - eosinophils
KW - exacerbations
KW - inhaled corticosteroids
KW - pharmacoepidemiology
KW - OBSTRUCTIVE PULMONARY-DISEASE
KW - PRACTICE RESEARCH DATALINK
KW - CLINICAL-PRACTICE
KW - COMORBIDITIES
KW - COUNT
KW - PREVENTION
KW - PNEUMONIA
KW - STABILITY
KW - BIOMARKER
KW - MARKERS
U2 - 10.1002/pds.4655
DO - 10.1002/pds.4655
M3 - Article
VL - 27
SP - 1191
EP - 1199
JO - Pharmacoepidemiology and Drug Safety
JF - Pharmacoepidemiology and Drug Safety
SN - 1053-8569
IS - 11
ER -